Join
Live feed
·
INSIDERFilingvia Quantisnow
Stoke Therapeutics Inc. logo

CHIEF MEDICAL OFFICER Ticho Barry sold $27,494 worth of shares (1,051 units at $26.16) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 19,059 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STOK (Stoke Therapeutics Inc.) and more on Quantisnow.